II 

108TH CONGRESS 

2D SESSION H. R. 5213

IN THE SENATE OF THE UNITED STATES 

OCTOBER 8, 2004

Received 

AN ACT

To expand research information regarding multidisciplinary 

research projects and epidemiological studies.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

HR 5213 RDS 

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Research Review Act 

3 of 2004’’. 

4 SEC. 2. MULTI-DISCIPLINARY RESEARCH TEAM AND CON5 SORTIA REPORT. 

6 (a) IN GENERAL.—The Secretary of Health and 

7 Human Services (referred to in this Act as the ‘‘Sec8 retary’’), in coordination with the Director of the National 

9 Institutes of Health, shall prepare a report outlining the 

10 methods by which the Roadmap for Medical Research, an 

11 initiative of such Institutes, has advanced the use of multi12 disciplinary research teams and consortia of research in13 stitutions to advance treatments, develop new therapies, 

14 and collaborate on clinical trials, including with respect 

15 to spinal cord injury and paralysis research. 

16 (b) REPORT.—Not later than February 1, 2005, the 

17 Secretary shall submit the report under subsection (a) to 

18 the Committee on Energy and Commerce of the House 

19 of Representatives and to the Committee on Health, Edu20 cation, Labor, and Pensions of the Senate. 

21 SEC. 3. EPIDEMIOLOGICAL STUDY REPORT. 

22 (a) IN GENERAL.—The Secretary, acting through the 

23 Director of the Centers for Disease Control and Preven24 tion, shall prepare a report outlining the epidemiological 

25 studies currently under way at such Centers, future 

26 planned studies, the criteria involved in determining what 
3

HR 5213 RDS 

1 epidemiological studies to conduct, defer, or suspend, and 

2 the scope of those studies, including with respect to the 

3 inflammatory bowel disease epidemiological study. The re4 port shall include a description of the activities the Cen5 ters for Disease Control and Prevention undertakes to es6 tablish partnerships with research and patient advocacy 

7 communities to expand epidemiological studies. 

8 (b) REPORT.—Not later than May 1, 2005, the Sec9 retary shall submit the report under subsection (a) to the 

10 Committee on Energy and Commerce of the House of 

11 Representatives and to the Committee on Health, Edu12 cation, Labor, and Pensions of the Senate. 

13 SEC. 4. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE 

14 ON MEDICARE AND MEDICAID COVERAGE 

15 STANDARDS. 

16 (a) IN GENERAL.—The Comptroller General of the 

17 United States shall conduct a study on the coverage stand18 ards that, under the programs under titles XVIII and XIX 

19 of the Social Security Act (commonly known as Medicare 

20 and Medicaid, respectively), apply to patients with inflam21 matory bowel disease for the following therapies: 

22 (1) Parenteral nutrition. 

23 (2) Enteral nutrition formula. 

24 (3) Medically necessary food products. 

25 (4) Ostomy supplies. 
4

HR 5213 RDS 

1 (5) Therapies approved by the Food and Drug 

2 Administration for Crohn’s disease and ulcerative 

3 colitis. 

4 (b) CONTENT.—The study under subsection (a) shall 

5 take into account the appropriate outpatient or home 

6 health care delivery settings. 

7 (c) REPORT.—Not later than six months after the 

8 date of the enactment of this Act, the Comptroller General 

9 shall submit to the Congress a report describing the find10 ings of the study under subsection (a). 

11 SEC. 5. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE 

12 INVOLVING DISABILITY INSURANCE. 

13 (a) IN GENERAL.—The Comptroller General of the 

14 United States shall conduct a study of the problems pa15 tients encounter when applying for disability insurance 

16 benefits under title II of the Social Security Act. The 

17 study shall include recommendations for improving the ap18 plication process for patients with inflammatory bowel dis19 ease. 

20 (b) REPORT.—Not later than six months after the 

21 date of the enactment of this Act, the Comptroller General 
5

HR 5213 RDS 

1 shall submit to the Congress a report describing the find2 ings of the study under subsection (a).

Passed the House of Representatives October 7, 

2004. 

Attest: JEFF TRANDAHL, 

Clerk.